Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Production of isocladosporin" refers to the fungal biosynthetic pathway responsible for generating the secondary metabolite isocladosporin, a process primarily documented in the fungus Cladosporium cladosporioides [2, 3]. It is characterized as a biological process or metabolic pathway rather than a discrete therapeutic target molecule, such as a receptor or enzyme. This biosynthetic route involves a coordinated gene cluster encoding specialized enzymes, specifically highly reducing and non-reducing iterative type I polyketide synthases (PKS), such as Cla2 and Cla3 [2, 3]. Isocladosporin itself is a diastereomer of cladosporin, a natural product recognized for its potent antimalarial properties through the selective inhibition of Plasmodium falciparum cytosolic lysyl-tRNA synthetase (PfKRS) [1, 6, 9]. While isocladosporin has been investigated for its own biological activities, including herbicidal and antibacterial effects, the production pathway itself is a subject of study for metabolic engineering and chemical ecology rather than a direct target for drug intervention [3, 7].
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Production of isocladosporin.